Cancer Family
Malignant Skin Neoplasm
CI-CAN-00000250Explore in graph →
320 active trials14 approved drugs64 evidence items
- NCIt
- C2920
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000250Explore in graph →
Clinical trials
1,248 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (202)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02192021 | Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL)(MNA-D) | completed | Phase 1 | 20 | Falo, Louis, MDOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT04925713 | IFx-Hu2.0 for the Treatment of Patients With Skin Cancer | completed | Phase 1 | 5 | TuHURA Biosciences, Inc.INDUSTRY | 1 | Aug 2, 2024 | clinicaltrials |
| NCT04091672 |
| RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction |
| completed |
| N/A |
| 65 |
| Avita MedicalINDUSTRY |
| 1 |
| Jul 30, 2024 |
| clinicaltrials |
| NCT05079113 | Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting | completed | — | 73 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT02576496 | Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies | completed | Phase 1 | 106 | Mundipharma Research LimitedINDUSTRY | 7 | Jul 25, 2024 | clinicaltrials |
| NCT05619471 | VIO Imaging for Skin Tissue Assessment (VISTA)(VISTA) | completed | N/A | 65 | Enspectra HealthINDUSTRY | 1 | Jul 25, 2024 | clinicaltrials |
| NCT05713760 | Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults | completed | Phase 2 | 5 | Austin Institute for Clinical ResearchNETWORK | 1 | Jul 19, 2024 | clinicaltrials |
| NCT02964559 | Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer | completed | Phase 2 | 11 | Emory UniversityOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT05121207 | SkIN hydrAtion Evaluation With TeRAhertz Scanning(SINATRA) | completed | N/A | 79 | University Hospitals Coventry and Warwickshire NHS TrustOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT00341939 | Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data | completed | — | 484 | National Cancer Institute (NCI)NIH | 1 | Jun 13, 2024 | clinicaltrials |
| NCT01226472 | Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001 | completed | Phase 2 | 1 | Kyowa Kirin Co., Ltd.INDUSTRY | 1 | Apr 25, 2024 | clinicaltrials |
| NCT01728805 | Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL | completed | Phase 3 | 372 | Kyowa Kirin, Inc.INDUSTRY | 11 | Apr 25, 2024 | clinicaltrials |
| NCT03265678 | Skin Ageing Signatures and Cancer(SASAC) | completed | — | 10 | Queen Mary University of LondonOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT01931644 | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | completed | — | 17,667 | Sanguine BiosciencesINDUSTRY | 1 | Apr 18, 2024 | clinicaltrials |
| NCT04059588 | A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin | completed | Phase 1 | 16 | Rockefeller UniversityOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT04411810 | SpotCheck: Comparison of Enhanced Telemedicine Versus In-person Evaluation for the Diagnosis of Skin Cancer | completed | N/A | 149 | NYU Langone HealthOTHER | 1 | Apr 8, 2024 | clinicaltrials |
| NCT02519322 | Neoadjuvant and Adjuvant Checkpoint Blockade | completed | Phase 2 | 53 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT01588015 | Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant | completed | Phase 1 | 36 | City of Hope Medical CenterOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT03590054 | Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies | completed | Phase 1 | 35 | Rahul AggarwalOTHER | 1 | Mar 22, 2024 | clinicaltrials |
| NCT03110159 | DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients | completed | Phase 1 / Phase 2 | 8 | Medical Dermatology SpecialistsOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT03246412 | Nevus Doctor Clinical Decision Support for GPs | completed | N/A | 35 | University Hospital of North NorwayOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT02177006 | Helping Children be Safe Outdoors With Sun Protection | completed | — | 840 | Northwestern UniversityOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT02168140 | CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma | completed | Phase 1 | 16 | Wake Forest University Health SciencesOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT05410964 | Non-Linear Imaging of Skin In Vivo(VISION) | completed | — | 122 | Enspectra HealthINDUSTRY | 1 | Jan 30, 2024 | clinicaltrials |
| NCT00046189 | Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum | completed | — | 301 | National Cancer Institute (NCI)NIH | 1 | Jan 8, 2024 | clinicaltrials |
| NCT03782727 | ObservAtional Study to Investigate Surgical Site Infection in Ulcerated Skin Cancers(OASIS) | completed | — | 148 | Cardiff and Vale University Health BoardOTHER_GOV | 1 | Dec 21, 2023 | clinicaltrials |
| NCT02324608 | Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer | completed | N/A | 15 | Rutgers, The State University of New JerseyOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT03229278 | Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma | completed | Phase 1 | 14 | Rutgers, The State University of New JerseyOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT06152367 | Immunization With Autologous Dendritic Cells and Tumor Lysates in Melanoma Patients | completed | Phase 1 / Phase 2 | 90 | University of ChileOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT01523223 | Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies | completed | Phase 1 | 16 | Robert LowskyOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT00047060 | Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome | completed | Phase 1 / Phase 2 | 5 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Nov 14, 2023 | clinicaltrials |
| NCT03701295 | Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement | completed | Phase 1 / Phase 2 | 1 | National Cancer Institute (NCI)NIH | 1 | Oct 18, 2023 | clinicaltrials |
| NCT02304458 | Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas | completed | Phase 1 / Phase 2 | 140 | National Cancer Institute (NCI)NIH | 2 | Oct 17, 2023 | clinicaltrials |
| NCT01000753 | Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma | completed | — | 174 | Children's Oncology GroupNETWORK | 4 | Oct 3, 2023 | clinicaltrials |
| NCT03602079 | Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | completed | Phase 1 / Phase 2 | 49 | Klus Pharma Inc.INDUSTRY | 1 | Aug 3, 2023 | clinicaltrials |
| NCT04576416 | Artificial Intelligence Augmented Training in Skin Cancer Diagnostics for General Practitioners(AISC-GP) | completed | N/A | 115 | Herlev HospitalOTHER | 1 | Jul 25, 2023 | clinicaltrials |
| NCT04456140 | Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study | completed | Phase 1 | 230 | Mayo ClinicOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05493826 | Real World Study on the Use of Cemiplimab in Adult Patients in UK(REACT-CEMI) | completed | — | 110 | SanofiINDUSTRY | 1 | Jul 14, 2023 | clinicaltrials |
| NCT03419637 | Mobile Devices as Educational Skin History Tools | completed | N/A | 70 | University of PennsylvaniaOTHER | 1 | Jun 29, 2023 | clinicaltrials |
| NCT05380635 | PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma | completed | Phase 2 | 9 | SoligenixINDUSTRY | 1 | Jun 7, 2023 | clinicaltrials |
| NCT00071071 | Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin. | completed | Phase 2 | 25 | GenmabINDUSTRY | 1 | May 18, 2023 | clinicaltrials |
| NCT00896493 | Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma | completed | Phase 2 | 38 | Stanford UniversityOTHER | 1 | May 11, 2023 | clinicaltrials |
| NCT05389085 | Fast Track Diagnosis of Skin Cancer by Advanced Imaging Technologies and Tumour Tapestripping | completed | N/A | 75 | University Hospital Bispebjerg and FrederiksbergOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05842421 | Imaging Methods for the Diagnosis of Non-melanoma Skin Cancer and Its Precursors | completed | N/A | 250 | Technische Universität DresdenOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT00071084 | Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin. | completed | Phase 2 | 22 | GenmabINDUSTRY | 4 | Apr 28, 2023 | clinicaltrials |
| NCT00392561 | Bangladesh Vitamin E and Selenium Trial(BEST) | completed | N/A | 7,000 | University of ChicagoOTHER | 1 | Apr 26, 2023 | clinicaltrials |
| NCT02546440 | Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL)(DMF-CTCL) | completed | Phase 2 | 25 | Universitätsmedizin MannheimOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT03122366 | TLR4 Polymorphisms and Risk of Skin Cancer | completed | — | 392 | University of Alabama at BirminghamOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT01662713 | Optical Frequency Domain Imaging for Non-melanoma Skin Cancers(OFDI) | completed | N/A | 10 | Massachusetts General HospitalOTHER | 1 | Mar 15, 2023 | clinicaltrials |
| NCT03096548 | Sun Safety Ink! A Sun Safety Program for the Tattoo Community | completed | N/A | 1,820 | Klein Buendel, Inc.INDUSTRY | 1 | Feb 6, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Aug 9, 2024source: clinicaltrials